Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where H. Regaieg is active.

Publication


Featured researches published by H. Regaieg.


International Journal of Pharmacovigilance | 2017

Fatal anaphylactic reaction to intravenous infusion of Ondansetron: a report of two cases

Bouraoui Ouni; Nessrine Bensayed; Neila Fathallah; Raoudha Slim; H. Regaieg; B. Achour; Yosra Benyoussef; Abderrahim Khelif; Chaker Ben Salem

Ondansetron is a selective 5 hydroxy-tryptamine 3 (5-HT3) receptor antagonist widely used as an effective antiemetic drug especially for the prevention of chemotherapy-induced nausea and vomiting [1]. The efficacy of ondansetron has been reported in several studies and it is reported to be a well-tolerated drug [2]. The most common side effects reported to ondansetron are headaches, diarrhea, constipation, fever and dizziness [3-5]. Anaphylactic reaction to ondansetron is rarely reported [6,7]. Abstract


Archives De Pediatrie | 2016

Leucémie myélomonocytaire juvénile : à propos de trois cas

I. Ghariani; N. Jmili-Braham; H. Regaieg; B. Achour; Y. Ben Youssef; H. Sendi; L. Bakir; M. Kortas

Juvenile myelomonocytic leukemia (JMML), previously known as juvenile chronic myeloid leukemia (JCML), is a rare, myelodysplastic-myeloproliferative disease typically presenting in early childhood. This disorder is difficult to distinguish from other myeloproliferative syndromes such as chronic myeloid leukemia (CML) because of the similarities in their clinical and bone marrow findings. However, because of its unique biological characteristics such as absolute monocytosis with dysplasia, absence of Philadelphia chromosome or BCR-ABL fusion protein, hypergammaglobulinemia, and raised fetal hemoglobin level, this disorder does not satisfy the criteria for inclusion in the CML or chronic myelomonocytic leukemia (CMML) group, as seen in adult patients. We describe three cases of JMML, who had very similar clinical and laboratory findings.


International Blood Research & Reviews | 2014

Primary Testicular Lymphoma: A Study of 11 Cases

H. Regaieg; N. Ben Sayed; Y. Ben Youssef; B. Achour; S. Hmissa; H. El Omri; Abderrahim Khelif

Primary testicular lymphoma(PTL) is an uncommon extranodal presentation constituting 1% of all NHL and 5% of all testicular neoplasm. The objective of our study was to identify the presenting signs and symptoms, treatment and outcome of patients with testicular lymphoma diagnosed atthe Hematology department of Farhat Hached University Hospital from 1997 to 2007 and to perform bibliography review about this pathology. Eleven cases were identified; the median age was 61 years (range:31-83).All patients presented with testicular and s crotal swelling or mass.B symptoms (recurrent fever of>38∫C temperature, night sweets and unexplained weight loss of>10% of the body weight within six months prior to diagnosis) were present in 6 patients. According to the


Bulletin Du Cancer | 2017

ARLTS1, potential candidate gene in familial aggregation of hematological malignancies

Walid Sabri Hamadou; Sawsen Besbes; Rahma Mani; Violaine Bourdon; Yosra Ben Youssef; B. Achour; H. Regaieg; François Eisinger; Véronique Mari; Paul Gesta; Hélène Dreyfus; Valérie Bonadona; Catherine Dugast; Hélène Zattara; Laurence Faivre; Testsuro Noguchi; Abderrahim Khelif; Hagay Sobol; Zohra Soua


Annals of Hematology | 2016

Mutational analysis of JAK2, CBL, RUNX1, and NPM1 genes in familial aggregation of hematological malignancies

Walid Sabri Hamadou; Violaine Bourdon; Pascaline Gaildrat; Sawsen Besbes; Aurelie Fabre; Yosra Ben Youssef; H. Regaieg; Mohamed Adnène Laatiri; François Eisinger; Véronique Mari; Paul Gesta; Hélène Dreyfus; Valérie Bonadona; Catherine Dugast; Hélène Zattara; Laurence Faivre; Saloua Yacoub Jemni; Testsuro Noguchi; Abderrahim Khelif; Hagay Sobol; Zohra Soua


Revue de Médecine Interne | 2014

Association anémie hémolytique auto-immune et maladies auto-immunes

J. Anoun; B. Achour; A. Rezgui; H. Regaieg; Y. Ben Youssef; Abderrahim Khelif


Revue Francaise D Allergologie | 2017

Choc anaphylactique à l’ondansétron

Bouraoui Ouni; R. Slim; Neila Fathallah; N. Bensayed; H. Regaieg; B. Achour; Y. Ben Youssef; Abderrahim Khelif; C. Ben Salem


Brazilian Journal of Medical and Biological Research | 2017

Minimal residual disease detection in Tunisian B-acute lymphoblastic leukemia based on immunoglobulin gene rearrangements.

Sawsen Besbes; Walid-Sabri Hamadou; M.L. Boulland; Yosra Ben Youssef; B. Achour; H. Regaieg; Abderrahim Khelif; T. Fest; Zohra Soua


Journal of Neuroradiology | 2014

Cerebral sinus venous thrombosis due to asparaginase therapy

B. Achour; A. Achour; H. Regaieg; H. Zaghouani; S. Majdoub; Y. Ben Youssef; C. Kraiem; Abderrahim Khelif


Journal of Neuroradiology | 2014

Aspergillose cérébrale en hématologie : apport de l’imagerie. À propos de deux cas

B. Achour; A. Achour; H. Regaieg; H. Zaghouani; S. Majdoub; Y. Ben Youssef; C. Kraiem; Abderrahim Khelif

Collaboration


Dive into the H. Regaieg's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge